English
Home > Products > CAS:57-83-0

China CAS:57-83-0 Manufacturer

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for CAS:57-83-0, With our rules of " small business track record, partner trust and mutual benefit", welcome all of you to definitely work together , expand with each other.
CAS:57-83-0, Our aim is to help customers realize their goals. We have been making great efforts to achieve this win-win situation and sincerely welcome you to join us. In a word, when you choose us, you choose a perfect life. Welcome to visit our factory and welcome your order! For further inquiries, remember to do not hesitate to contact us.

Related Products

Hot Products

  • Desonide

    Desonide

    Desonide has USP and EP specifications. DMF available.

    CAS:638-94-8

  • Nintedanib Esylate

    Nintedanib Esylate

    Nintedanib Esylate has in-house specification. DMF available.

    CAS:656247-18-6

  • Mometasone Furoate

    Mometasone Furoate

    Mometasone furoate has CP、EP、USP specifications. DMF under filing.

    CAS:83919-23-7

  • Revefenacin

    Revefenacin

    Revefenacin has In-house specification. DMF approved.

    CAS:864750-70-9

  • Cbz-Valganciclovir

    Cbz-Valganciclovir

    Cbz-Valganciclovir,N-Carbobenzyloxy-L-valinyl-ganciclovir (cas# 194154-40-0) is a compound useful in organic synthesis.

    CAS:194154-40-0

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • Related Blog
  • Reviews

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • Budesonide: A Great Product in the Treatment of Respiratory Ailments

    Please feel free to reach out to us for more information on product details.

  • Welcome to CPhI Korea 2024

    CPhI Korea 2024 will be held at COEX, Seoul Hall A from August 27 to 29, our booth number is M27.

  • What Is Finasteride and How Does It Work for Hair Loss and Prostate Health

    Finasteride is one of the most widely researched and prescribed medications for treating male pattern hair loss and benign prostatic hyperplasia (BPH). By targeting the hormonal pathways responsible for hair follicle miniaturization and prostate enlargement, Finasteride has become a cornerstone pharmaceutical ingredient in dermatology and urology. This in-depth guide explores how Finasteride works, its benefits, dosage, safety profile, side effects, comparisons with alternatives, and why global pharmaceutical manufacturers such as Humanwell play a crucial role in its production and supply.

  • How Can the Right Intermediates Category Simplify Pharmaceutical Sourcing?

    Selecting the right Intermediates Category is more than browsing a product list. For many buyers, it shapes sourcing speed, technical communication, documentation efficiency, batch consistency, and long-term supply confidence.

  • What Should Buyers Look for in an APIs Category?

    Choosing from an APIs Category is rarely as simple as comparing product names on a list. Buyers often need to balance regulatory expectations, quality consistency, technical support, supply continuity, and the practical realities of scaling from evaluation to commercial procurement.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept